The global market for Pet Vaccine was valued at US$ 3836 million in the year 2024 and is projected to reach a revised size of US$ 6221 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Pet Vaccine Market

Pet vaccines are biological preparations designed to stimulate an immune response in pets, protecting them from infectious diseases caused by viruses, bacteria, and other pathogens. These vaccines help prevent severe illnesses such as rabies, distemper, parvovirus, and feline leukemia, reducing mortality rates and improving the overall health of companion animals. Vaccination is a crucial aspect of preventive veterinary care and is commonly administered to dogs, cats, and other domesticated animals based on specific vaccination schedules.

With advancements in veterinary medicine, modern pet vaccines are becoming more effective, safer, and tailored to specific breeds and regional disease risks. Innovations such as recombinant vaccines and mRNA-based vaccines are enhancing immune responses with fewer side effects. As pet ownership rises globally and awareness of animal health increases, the demand for high-quality pet vaccines continues to grow, supporting both public health and animal welfare.

Market Drivers:

The pet vaccine market is primarily driven by the increasing pet ownership worldwide and a growing awareness of animal health and preventive care. As more people adopt pets, the demand for vaccines to protect them from infectious diseases rises, especially with the expansion of the pet care industry. Moreover, advancements in veterinary vaccines, including more effective and safer vaccines, are improving vaccination outcomes and encouraging wider use. Public health initiatives and regulations, such as rabies vaccination requirements, also play a role in fueling market growth. Additionally, rising disposable incomes, particularly in emerging markets, are enabling pet owners to spend more on veterinary care, including vaccinations.

Market Challenges:

One of the major challenges facing the pet vaccine market is the high cost of some vaccines, which can be a barrier to regular vaccination, especially for pet owners in lower-income regions. Furthermore, the increasing complexity of vaccine schedules and the need for specialized veterinary care may slow down adoption rates in some areas. In addition, the emergence of counterfeit or low-quality vaccines poses a significant threat to market growth and animal health. Regulatory barriers and inconsistencies across different regions can also hinder the efficient distribution and accessibility of vaccines, especially in emerging markets with less-developed veterinary infrastructure.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Vaccine.

The Pet Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pet Vaccine Market Report

Report Metric	Details
Report Name	Pet Vaccine Market
Accounted market size in year	US$ 3836 million
Forecasted market size in 2031	US$ 6221 million
CAGR	7.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Nasal Administration Injection Other
Segment by Application	Cat Dog Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim, Zoetis, Elanco Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group, Parnell, CAHIC, Ringpu, Jinyu Group, Keqian Biology, Kyoritsu Seiyaku
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pet Vaccine Market growing?

Ans: The Pet Vaccine Market witnessing a CAGR of 7.1% during the forecast period 2025-2031.

What is the Pet Vaccine Market size in 2031?

Ans: The Pet Vaccine Market size in 2031 will be US$ 6221 million.

Who are the main players in the Pet Vaccine Market report?

Ans: The main players in the Pet Vaccine Market are Boehringer Ingelheim, Zoetis, Elanco Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group, Parnell, CAHIC, Ringpu, Jinyu Group, Keqian Biology, Kyoritsu Seiyaku

What are the Application segmentation covered in the Pet Vaccine Market report?

Ans: The Applications covered in the Pet Vaccine Market report are Cat, Dog, Other

What are the Type segmentation covered in the Pet Vaccine Market report?

Ans: The Types covered in the Pet Vaccine Market report are Nasal Administration, Injection, Other

1 Pet Vaccine Market Overview

1.1 Product Definition

1.2 Pet Vaccine by Type

1.2.1 Global Pet Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Nasal Administration

1.2.3 Injection

1.2.4 Other

1.3 Pet Vaccine by Application

1.3.1 Global Pet Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Cat

1.3.3 Dog

1.3.4 Other

1.4 Global Pet Vaccine Market Size Estimates and Forecasts

1.4.1 Global Pet Vaccine Revenue 2020-2031

1.4.2 Global Pet Vaccine Sales 2020-2031

1.4.3 Global Pet Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pet Vaccine Market Competition by Manufacturers

2.1 Global Pet Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pet Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pet Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pet Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pet Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pet Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Pet Vaccine, Date of Enter into This Industry

2.8 Global Pet Vaccine Market Competitive Situation and Trends

2.8.1 Global Pet Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pet Vaccine Players Market Share by Revenue

2.8.3 Global Pet Vaccine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pet Vaccine Market Scenario by Region

3.1 Global Pet Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pet Vaccine Sales by Region: 2020-2031

3.2.1 Global Pet Vaccine Sales by Region: 2020-2025

3.2.2 Global Pet Vaccine Sales by Region: 2026-2031

3.3 Global Pet Vaccine Revenue by Region: 2020-2031

3.3.1 Global Pet Vaccine Revenue by Region: 2020-2025

3.3.2 Global Pet Vaccine Revenue by Region: 2026-2031

3.4 North America Pet Vaccine Market Facts & Figures by Country

3.4.1 North America Pet Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pet Vaccine Sales by Country (2020-2031)

3.4.3 North America Pet Vaccine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pet Vaccine Market Facts & Figures by Country

3.5.1 Europe Pet Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pet Vaccine Sales by Country (2020-2031)

3.5.3 Europe Pet Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pet Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Pet Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pet Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Pet Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pet Vaccine Market Facts & Figures by Country

3.7.1 Latin America Pet Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pet Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Pet Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pet Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Pet Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pet Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pet Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pet Vaccine Sales by Type (2020-2031)

4.1.1 Global Pet Vaccine Sales by Type (2020-2025)

4.1.2 Global Pet Vaccine Sales by Type (2026-2031)

4.1.3 Global Pet Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Pet Vaccine Revenue by Type (2020-2031)

4.2.1 Global Pet Vaccine Revenue by Type (2020-2025)

4.2.2 Global Pet Vaccine Revenue by Type (2026-2031)

4.2.3 Global Pet Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Pet Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pet Vaccine Sales by Application (2020-2031)

5.1.1 Global Pet Vaccine Sales by Application (2020-2025)

5.1.2 Global Pet Vaccine Sales by Application (2026-2031)

5.1.3 Global Pet Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Pet Vaccine Revenue by Application (2020-2031)

5.2.1 Global Pet Vaccine Revenue by Application (2020-2025)

5.2.2 Global Pet Vaccine Revenue by Application (2026-2031)

5.2.3 Global Pet Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Pet Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Company Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Boehringer Ingelheim Pet Vaccine Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 Zoetis

6.2.1 Zoetis Company Information

6.2.2 Zoetis Description and Business Overview

6.2.3 Zoetis Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Zoetis Pet Vaccine Product Portfolio

6.2.5 Zoetis Recent Developments/Updates

6.3 Elanco Animal Health

6.3.1 Elanco Animal Health Company Information

6.3.2 Elanco Animal Health Description and Business Overview

6.3.3 Elanco Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Elanco Animal Health Pet Vaccine Product Portfolio

6.3.5 Elanco Animal Health Recent Developments/Updates

6.4 Merck Animal Health

6.4.1 Merck Animal Health Company Information

6.4.2 Merck Animal Health Description and Business Overview

6.4.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Animal Health Pet Vaccine Product Portfolio

6.4.5 Merck Animal Health Recent Developments/Updates

6.5 Virbac

6.5.1 Virbac Company Information

6.5.2 Virbac Description and Business Overview

6.5.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Virbac Pet Vaccine Product Portfolio

6.5.5 Virbac Recent Developments/Updates

6.6 Dechra Veterinary Products

6.6.1 Dechra Veterinary Products Company Information

6.6.2 Dechra Veterinary Products Description and Business Overview

6.6.3 Dechra Veterinary Products Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Dechra Veterinary Products Pet Vaccine Product Portfolio

6.6.5 Dechra Veterinary Products Recent Developments/Updates

6.7 Ceva

6.7.1 Ceva Company Information

6.7.2 Ceva Description and Business Overview

6.7.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Ceva Pet Vaccine Product Portfolio

6.7.5 Ceva Recent Developments/Updates

6.8 Vetoquinol

6.8.1 Vetoquinol Company Information

6.8.2 Vetoquinol Description and Business Overview

6.8.3 Vetoquinol Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Vetoquinol Pet Vaccine Product Portfolio

6.8.5 Vetoquinol Recent Developments/Updates

6.9 Meiji

6.9.1 Meiji Company Information

6.9.2 Meiji Description and Business Overview

6.9.3 Meiji Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Meiji Pet Vaccine Product Portfolio

6.9.5 Meiji Recent Developments/Updates

6.10 Ouro Fino Saude

6.10.1 Ouro Fino Saude Company Information

6.10.2 Ouro Fino Saude Description and Business Overview

6.10.3 Ouro Fino Saude Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Ouro Fino Saude Pet Vaccine Product Portfolio

6.10.5 Ouro Fino Saude Recent Developments/Updates

6.11 Animalcare Group

6.11.1 Animalcare Group Company Information

6.11.2 Animalcare Group Description and Business Overview

6.11.3 Animalcare Group Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Animalcare Group Pet Vaccine Product Portfolio

6.11.5 Animalcare Group Recent Developments/Updates

6.12 Parnell

6.12.1 Parnell Company Information

6.12.2 Parnell Description and Business Overview

6.12.3 Parnell Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Parnell Pet Vaccine Product Portfolio

6.12.5 Parnell Recent Developments/Updates

6.13 CAHIC

6.13.1 CAHIC Company Information

6.13.2 CAHIC Description and Business Overview

6.13.3 CAHIC Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 CAHIC Pet Vaccine Product Portfolio

6.13.5 CAHIC Recent Developments/Updates

6.14 Ringpu

6.14.1 Ringpu Company Information

6.14.2 Ringpu Description and Business Overview

6.14.3 Ringpu Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Ringpu Pet Vaccine Product Portfolio

6.14.5 Ringpu Recent Developments/Updates

6.15 Jinyu Group

6.15.1 Jinyu Group Company Information

6.15.2 Jinyu Group Description and Business Overview

6.15.3 Jinyu Group Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Jinyu Group Pet Vaccine Product Portfolio

6.15.5 Jinyu Group Recent Developments/Updates

6.16 Keqian Biology

6.16.1 Keqian Biology Company Information

6.16.2 Keqian Biology Description and Business Overview

6.16.3 Keqian Biology Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Keqian Biology Pet Vaccine Product Portfolio

6.16.5 Keqian Biology Recent Developments/Updates

6.17 Kyoritsu Seiyaku

6.17.1 Kyoritsu Seiyaku Company Information

6.17.2 Kyoritsu Seiyaku Description and Business Overview

6.17.3 Kyoritsu Seiyaku Pet Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Kyoritsu Seiyaku Pet Vaccine Product Portfolio

6.17.5 Kyoritsu Seiyaku Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pet Vaccine Industry Chain Analysis

7.2 Pet Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pet Vaccine Production Mode & Process Analysis

7.4 Pet Vaccine Sales and Marketing

7.4.1 Pet Vaccine Sales Channels

7.4.2 Pet Vaccine Distributors

7.5 Pet Vaccine Customer Analysis

8 Pet Vaccine Market Dynamics

8.1 Pet Vaccine Industry Trends

8.2 Pet Vaccine Market Drivers

8.3 Pet Vaccine Market Challenges

8.4 Pet Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Vetoquinol

Boehringer Ingelheim

Ceva

Merck Animal Health

Virbac

Zoetis Inc

Elanco Animal Health

Dechra Veterinary Products

List of Tables

Table 1. Global Pet Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pet Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pet Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pet Vaccine Sales (K Doses) of Key Manufacturers (2020-2025)

Table 5. Global Pet Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pet Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pet Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pet Vaccine Average Price (USD/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pet Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pet Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pet Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Pet Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pet Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pet Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pet Vaccine Sales by Region (2020-2025) & (K Doses)

Table 18. Global Pet Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Pet Vaccine Sales by Region (2026-2031) & (K Doses)

Table 20. Global Pet Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Pet Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pet Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Pet Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pet Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Pet Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pet Vaccine Sales by Country (2020-2025) & (K Doses)

Table 27. North America Pet Vaccine Sales by Country (2026-2031) & (K Doses)

Table 28. North America Pet Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pet Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pet Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pet Vaccine Sales by Country (2020-2025) & (K Doses)

Table 32. Europe Pet Vaccine Sales by Country (2026-2031) & (K Doses)

Table 33. Europe Pet Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pet Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pet Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pet Vaccine Sales by Region (2020-2025) & (K Doses)

Table 37. Asia Pacific Pet Vaccine Sales by Region (2026-2031) & (K Doses)

Table 38. Asia Pacific Pet Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pet Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pet Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pet Vaccine Sales by Country (2020-2025) & (K Doses)

Table 42. Latin America Pet Vaccine Sales by Country (2026-2031) & (K Doses)

Table 43. Latin America Pet Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pet Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pet Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pet Vaccine Sales by Country (2020-2025) & (K Doses)

Table 47. Middle East and Africa Pet Vaccine Sales by Country (2026-2031) & (K Doses)

Table 48. Middle East and Africa Pet Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pet Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pet Vaccine Sales (K Doses) by Type (2020-2025)

Table 51. Global Pet Vaccine Sales (K Doses) by Type (2026-2031)

Table 52. Global Pet Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Pet Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Pet Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pet Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pet Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Pet Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Pet Vaccine Price (USD/Dose) by Type (2020-2025)

Table 59. Global Pet Vaccine Price (USD/Dose) by Type (2026-2031)

Table 60. Global Pet Vaccine Sales (K Doses) by Application (2020-2025)

Table 61. Global Pet Vaccine Sales (K Doses) by Application (2026-2031)

Table 62. Global Pet Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Pet Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Pet Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pet Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pet Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Pet Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Pet Vaccine Price (USD/Dose) by Application (2020-2025)

Table 69. Global Pet Vaccine Price (USD/Dose) by Application (2026-2031)

Table 70. Boehringer Ingelheim Company Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Pet Vaccine Product

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. Zoetis Company Information

Table 76. Zoetis Description and Business Overview

Table 77. Zoetis Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 78. Zoetis Pet Vaccine Product

Table 79. Zoetis Recent Developments/Updates

Table 80. Elanco Animal Health Company Information

Table 81. Elanco Animal Health Description and Business Overview

Table 82. Elanco Animal Health Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 83. Elanco Animal Health Pet Vaccine Product

Table 84. Elanco Animal Health Recent Developments/Updates

Table 85. Merck Animal Health Company Information

Table 86. Merck Animal Health Description and Business Overview

Table 87. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 88. Merck Animal Health Pet Vaccine Product

Table 89. Merck Animal Health Recent Developments/Updates

Table 90. Virbac Company Information

Table 91. Virbac Description and Business Overview

Table 92. Virbac Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 93. Virbac Pet Vaccine Product

Table 94. Virbac Recent Developments/Updates

Table 95. Dechra Veterinary Products Company Information

Table 96. Dechra Veterinary Products Description and Business Overview

Table 97. Dechra Veterinary Products Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 98. Dechra Veterinary Products Pet Vaccine Product

Table 99. Dechra Veterinary Products Recent Developments/Updates

Table 100. Ceva Company Information

Table 101. Ceva Description and Business Overview

Table 102. Ceva Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 103. Ceva Pet Vaccine Product

Table 104. Ceva Recent Developments/Updates

Table 105. Vetoquinol Company Information

Table 106. Vetoquinol Description and Business Overview

Table 107. Vetoquinol Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 108. Vetoquinol Pet Vaccine Product

Table 109. Vetoquinol Recent Developments/Updates

Table 110. Meiji Company Information

Table 111. Meiji Description and Business Overview

Table 112. Meiji Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 113. Meiji Pet Vaccine Product

Table 114. Meiji Recent Developments/Updates

Table 115. Ouro Fino Saude Company Information

Table 116. Ouro Fino Saude Description and Business Overview

Table 117. Ouro Fino Saude Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 118. Ouro Fino Saude Pet Vaccine Product

Table 119. Ouro Fino Saude Recent Developments/Updates

Table 120. Animalcare Group Company Information

Table 121. Animalcare Group Description and Business Overview

Table 122. Animalcare Group Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 123. Animalcare Group Pet Vaccine Product

Table 124. Animalcare Group Recent Developments/Updates

Table 125. Parnell Company Information

Table 126. Parnell Description and Business Overview

Table 127. Parnell Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 128. Parnell Pet Vaccine Product

Table 129. Parnell Recent Developments/Updates

Table 130. CAHIC Company Information

Table 131. CAHIC Description and Business Overview

Table 132. CAHIC Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 133. CAHIC Pet Vaccine Product

Table 134. CAHIC Recent Developments/Updates

Table 135. Ringpu Company Information

Table 136. Ringpu Description and Business Overview

Table 137. Ringpu Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 138. Ringpu Pet Vaccine Product

Table 139. Ringpu Recent Developments/Updates

Table 140. Jinyu Group Company Information

Table 141. Jinyu Group Description and Business Overview

Table 142. Jinyu Group Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 143. Jinyu Group Pet Vaccine Product

Table 144. Jinyu Group Recent Developments/Updates

Table 145. Keqian Biology Company Information

Table 146. Keqian Biology Description and Business Overview

Table 147. Keqian Biology Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 148. Keqian Biology Pet Vaccine Product

Table 149. Keqian Biology Recent Developments/Updates

Table 150. Kyoritsu Seiyaku Company Information

Table 151. Kyoritsu Seiyaku Description and Business Overview

Table 152. Kyoritsu Seiyaku Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 153. Kyoritsu Seiyaku Pet Vaccine Product

Table 154. Kyoritsu Seiyaku Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Pet Vaccine Distributors List

Table 158. Pet Vaccine Customers List

Table 159. Pet Vaccine Market Trends

Table 160. Pet Vaccine Market Drivers

Table 161. Pet Vaccine Market Challenges

Table 162. Pet Vaccine Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pet Vaccine

Figure 2. Global Pet Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pet Vaccine Market Share by Type: 2024 & 2031

Figure 4. Nasal Administration Product Picture

Figure 5. Injection Product Picture

Figure 6. Other Product Picture

Figure 7. Global Pet Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Pet Vaccine Market Share by Application: 2024 & 2031

Figure 9. Cat

Figure 10. Dog

Figure 11. Other

Figure 12. Global Pet Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Pet Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global Pet Vaccine Sales (2020-2031) & (K Doses)

Figure 15. Global Pet Vaccine Average Price (USD/Dose) & (2020-2031)

Figure 16. Pet Vaccine Report Years Considered

Figure 17. Pet Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global Pet Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Pet Vaccine Players: Market Share by Revenue in Pet Vaccine in 2024

Figure 20. Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Pet Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Pet Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America Pet Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Pet Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe Pet Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Pet Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Pet Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Pet Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Latin America Pet Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Pet Vaccine Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Pet Vaccine Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Pet Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Pet Vaccine by Type (2020-2031)

Figure 56. Global Revenue Market Share of Pet Vaccine by Type (2020-2031)

Figure 57. Global Pet Vaccine Price (USD/Dose) by Type (2020-2031)

Figure 58. Global Sales Market Share of Pet Vaccine by Application (2020-2031)

Figure 59. Global Revenue Market Share of Pet Vaccine by Application (2020-2031)

Figure 60. Global Pet Vaccine Price (USD/Dose) by Application (2020-2031)

Figure 61. Pet Vaccine Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions